Published in J Clin Microbiol on July 01, 1991
Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol (2003) 3.27
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis (2002) 2.76
Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J Clin Microbiol (1992) 2.67
Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol (1994) 2.63
Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiol (1994) 2.40
Evaluation of previously assigned antibody concentrations in pneumococcal polysaccharide reference serum 89SF by the method of cross-standardization. Clin Diagn Lab Immunol (1998) 2.12
Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992. Clin Diagn Lab Immunol (1995) 2.00
An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study. J Clin Microbiol (2000) 1.97
Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides. Clin Diagn Lab Immunol (2003) 1.50
Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins. Clin Diagn Lab Immunol (2004) 1.44
Detection of antibody to recombinant Norwalk virus antigen in specimens from outbreaks of gastroenteritis. J Clin Microbiol (1993) 1.35
Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum. Clin Diagn Lab Immunol (2004) 1.21
The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK. Clin Exp Immunol (1993) 1.17
A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin Diagn Lab Immunol (1999) 1.17
Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity. J Virol (2006) 1.14
Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity. Infect Immun (2005) 1.13
Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses. J Virol (2004) 1.11
Treatment of batch in the detection, calibration, and quantification of immunoassays in large-scale epidemiologic studies. Epidemiology (2010) 1.07
Development and technical and clinical validation of a quantitative enzyme-linked immunosorbent assay for the detection of human antibodies to hepatitis B surface antigen in recipients of recombinant hepatitis B virus vaccine. Clin Vaccine Immunol (2009) 1.00
Assignment of additional anticapsular antibody concentrations to the Neisseria meningitidis group A, C, Y, and W-135 meningococcal standard reference serum CDC1992. Clin Diagn Lab Immunol (2002) 0.97
Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk. Transfusion (2013) 0.95
Diagnosis of norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant norwalk virus antigen. Clin Diagn Lab Immunol (2004) 0.91
AAVrh.10-mediated genetic delivery of bevacizumab to the pleura to provide local anti-VEGF to suppress growth of metastatic lung tumors. Gene Ther (2010) 0.87
Application of the checkerboard immunoblotting technique to the quantification of host biomarkers in gingival crevicular fluid. J Periodontol (2009) 0.87
Tear lacritin levels by age, sex, and time of day in healthy adults. Invest Ophthalmol Vis Sci (2012) 0.86
Cotinine in human placenta predicts induction of gene expression in fetal tissues. Drug Metab Dispos (2012) 0.84
Maternal smoking and the retinoid pathway in the developing lung. Respir Res (2012) 0.82
Genetic delivery of bevacizumab to suppress vascular endothelial growth factor-induced high-permeability pulmonary edema. Hum Gene Ther (2009) 0.81
Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens. Clin Vaccine Immunol (2013) 0.78
Quantifying antibody binding on protein microarrays using microarray nonlinear calibration. Biotechniques (2013) 0.78
Quantitative anti-PA IgG ELISA; assessment and comparability with the anthrax toxin neutralization assay in goats. BMC Vet Res (2013) 0.78
Dynamics of the murine humoral immune response to Neisseria meningitis group B capsular polysaccharide. Infect Immun (1998) 0.76
Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine. Hum Vaccin Immunother (2013) 0.76
Noncovalent association of protein and capsular polysaccharide on bacteria-sized latex beads as a model for polysaccharide-specific humoral immunity to intact gram-positive extracellular bacteria. J Immunol (2013) 0.76
Revisiting the dilution factor as vital parameter for sensitivity of ELISA assay in CSF and Plasma. Ann Neurosci (2015) 0.75
Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice. PLoS One (2014) 0.75
Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol (1978) 13.02
Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem (1974) 3.97
Rapid calculation of radioimmunoassay results. J Lab Clin Med (1969) 2.93
Computer analysis of radioligand assay and radioimmunoassay data. Acta Endocrinol Suppl (Copenh) (1970) 2.36
A versatile method for simultaneous analysis of families of curves. FASEB J (1988) 1.97
Robust estimation of standard curves for protein molecular weight and linear-duplex DNA base-pair number after gel electrophoresis. Anal Biochem (1986) 1.88
Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA). J Immunol Methods (1987) 1.79
Radioligand Assay. Biometrics (1976) 1.49
Two simple programs for the analysis of data from enzyme-linked immunosorbent (ELISA) assays on a programmable desk-top calculator. Anal Biochem (1981) 1.49
Two-site immunoenzymometric assays for serum IgG subclass infant/maternal ratios at full-term. J Immunol Methods (1988) 1.29
Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid. Infect Immun (1990) 1.20
The application of robust calibration to radioimmunoassay. Biometrics (1979) 1.09
A model-free approach to estimation of relative potency in dose-response curve analysis. Am J Physiol (1987) 1.08
Immunoglobulin M and G antibody responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccine. Infect Immun (1982) 1.05
Comparison of radioimmunoassay and enzyme-linked immunosorbent assay in measurement of antibodies to Neisseria meningitidis group A capsular polysaccharide. J Clin Microbiol (1984) 1.05
Statistical package for analysis of competition ELISA results. J Immunol Methods (1981) 0.99
Quantitation of IgG antibody to Streptococcus pneumoniae vaccine by ELISA and FAST-ELISA using tyraminated antigen. J Immunol Methods (1989) 0.90
A three-parameter Langmuir-type model for fitting standard curves of sandwich enzyme immunoassays with special attention to the alpha-fetoprotein assay. Anal Biochem (1987) 0.85
Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin Diagn Lab Immunol (1997) 4.65
Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol (1997) 4.28
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA (1999) 3.69
Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis (1999) 3.15
Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol (2001) 2.92
Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun (2000) 2.84
Rapid microprocedure for isolating detergent-insoluble outer membrane proteins from Haemophilus species. J Clin Microbiol (1986) 2.80
Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis (2001) 2.71
Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J Clin Microbiol (1992) 2.67
Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol (1994) 2.63
Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiol (1994) 2.40
Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J Infect Dis (1998) 2.11
Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. J Infect Dis (2000) 2.11
Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992. Clin Diagn Lab Immunol (1995) 2.00
Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model. Vaccine (2000) 2.00
An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study. J Clin Microbiol (2000) 1.97
Robust estimation of standard curves for protein molecular weight and linear-duplex DNA base-pair number after gel electrophoresis. Anal Biochem (1986) 1.88
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis (1997) 1.86
A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin Diagn Lab Immunol (1999) 1.81
Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis. J Clin Microbiol (2000) 1.80
Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr Res (1984) 1.79
Organization and transcription of DNA in chromosomes and mitochondria of Drosophila. Cold Spring Harb Symp Quant Biol (1974) 1.74
Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (1996) 1.71
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Vaccine (1998) 1.66
A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J Infect Dis (1995) 1.61
Sequence analysis of the 17-kilodalton-antigen gene from Rickettsia rickettsii. J Bacteriol (1987) 1.61
Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae. J Infect Dis (1999) 1.58
Methods for distinguishing gram-positive from gram-negative bacteria. J Clin Microbiol (1982) 1.57
Listeria monocytogenes ATCC 35152 and NCTC 7973 contain a nonhemolytic, nonvirulent variant. J Clin Microbiol (1987) 1.56
Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel. J Infect Dis (1994) 1.56
Purified 60-kilodalton Legionella protein antigen with Legionella-specific and nonspecific epitopes. J Clin Microbiol (1987) 1.54
Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team. J Clin Microbiol (2000) 1.48
Nonhemolytic Listeria monocytogenes mutants that are also noninvasive for mammalian cells in culture: evidence for coordinate regulation of virulence. Infect Immun (1990) 1.43
A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses. Clin Diagn Lab Immunol (1998) 1.42
Comparison of outer membrane protein and biochemical profiles of Haemophilus aegyptius and Haemophilus influenzae biotype III. J Clin Microbiol (1985) 1.38
Numerical analysis of normalized whole-cell protein profiles after sodium dodecyl sulphate-polyacrylamide gel electrophoresis. J Gen Microbiol (1986) 1.37
Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults. Infect Immun (1994) 1.35
Nucleotide sequence of htpB, the Legionella pneumophila gene encoding the 58-kilodalton (kDa) common antigen, formerly designated the 60-kDa common antigen. Infect Immun (1990) 1.33
Two-site immunoenzymometric assays for serum IgG subclass infant/maternal ratios at full-term. J Immunol Methods (1988) 1.29
Pneumococcal vaccines: history, current status, and future directions. Am J Med (1999) 1.25
Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine. Infect Immun (1998) 1.25
Biochemical, genetic, and epidemiologic characterization of Haemophilus influenzae biogroup aegyptius (Haemophilus aegyptius) strains associated with Brazilian purpuric fever. J Clin Microbiol (1988) 1.22
Potential virulence-associated factors in Brazilian purpuric fever. Brazilian Purpuric Fever Study Group. J Clin Microbiol (1989) 1.22
Quality of commercially produced Shigella serogrouping and serotyping antisera. J Clin Microbiol (1988) 1.21
Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate). Clin Diagn Lab Immunol (2001) 1.20
Detection of menaquinone-6 and a novel methyl-substituted menaquinone-6 in Campylobacter jejuni and Campylobacter fetus subsp. fetus. J Gen Microbiol (1983) 1.19
Limited diversity of Streptococcus pneumoniae psaA among pneumococcal vaccine serotypes. Infect Immun (1997) 1.18
Immunoreactivity of five monoclonal antibodies against the 37-kilodalton common cell wall protein (PsaA) of Streptococcus pneumoniae. Clin Diagn Lab Immunol (1998) 1.16
Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. J Infect Dis (1993) 1.14
Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy. J Trauma (1998) 1.12
Establishment of a new human pneumococcal standard reference serum, 007sp. Clin Vaccine Immunol (2011) 1.11
Immunologic characterization and specificity of three monoclonal antibodies against the 58-kilodalton protein of Legionella pneumophila. J Clin Microbiol (1991) 1.10
Diversity of RNA sequences in Drosophila melanogaster. Biochem Genet (1973) 1.07
Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease. Vaccine (1999) 1.07
Aerobic and anaerobic respiratory systems in Campylobacter fetus subsp. jejuni grown in atmospheres containing hydrogen. J Bacteriol (1982) 1.06
An infant rat model of bacteremia with Brazilian purpuric fever isolates of Hemophilus influenzae biogroup aegyptius. Brazilian Purpuric Fever Study Group. J Infect Dis (1989) 1.06
Immune serum to protein molecular weight standards for calibrating Western blots. Anal Biochem (1986) 1.02
Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G antibodies to Chlamydia pneumoniae. Clin Diagn Lab Immunol (2001) 1.00
Supplement 2000 (no. 44) to the Kauffmann-White scheme. Res Microbiol (2001) 0.98
Evaluation of monoclonal antibodies with specificity for human IgA, IgA subclasses and allotypes and secretory component. Results of an IUIS/WHO collaborative study. J Immunol Methods (1996) 0.96
Comparison of a pneumococcal common protein (PsaA) antibody ELISA and a PsaA immune complex ELISA for detection of pneumococcal serum antibody. Pathobiology (1998) 0.95
Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease. J Infect Dis (1997) 0.95
Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli. Vaccine (2000) 0.94
Outbreak of pneumonia in a long-term care facility: antecedent human parainfluenza virus 1 infection may predispose to bacterial pneumonia. J Am Geriatr Soc (1998) 0.94
Purification, partial characterization, and seroreactivity of a genuswide 60-kilodalton Legionella protein antigen. J Clin Microbiol (1988) 0.94
Analysis of immunoreactivity to a Streptococcus equi subsp. zooepidemicus M-like protein To confirm an outbreak of poststreptococcal glomerulonephritis, and sequences of M-like proteins from isolates obtained from different host species. J Clin Microbiol (2000) 0.91
Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library. Vaccine (2000) 0.90
Serogroup B and C serum bactericidal assays. Methods Mol Med (2001) 0.87
Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease. J Infect Dis (2000) 0.87
DNA sequence heterogeneity in the gene encoding a 60-kilodalton extracellular protein of Listeria monocytogenes and other Listeria species. Can J Microbiol (1992) 0.87
Immunoglobulin G subclass values in healthy black and white children. J Pediatr (1991) 0.86
Elderly immune response to a TI-2 antigen: heavy and light chain use and bactericidal activity to Neisseria meningitidis serogroup C polysaccharide. J Infect Dis (1999) 0.85
A murine model for the study of immune memory in response to pneumococcal conjugate vaccination. Vaccine (2004) 0.84
Genetic and immunologic characterization of a novel serotype 4, 15 strain of Neisseria meningitidis. FEMS Immunol Med Microbiol (2000) 0.83
Antibody response after immunization of Brazilian children with serogroup C meningococcal polysaccharide noncovalently complexed with outer membrane proteins. Braz J Med Biol Res (1995) 0.83
Characterization of P1-deficient isogenic mutant of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever. Microb Pathog (2000) 0.83
A filamentous-like mutant of Listeria monocytogenes with reduced expression of a 60-kilodalton extracellular protein invades and grows in 3T6 and Caco-2 cells. Can J Microbiol (1992) 0.82
Stable, conserved outer membrane epitope of strains of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever. Infect Immun (1992) 0.82
Selection of an immunogenic and protective epitope of the PsaA protein of Streptococcus pneumoniae using a phage display library. Hybridoma (2000) 0.82
Glucuronoxylomannan of Cryptococcus neoformans serotype D: structural analysis by gas-liquid chromatography-mass spectrometry and by 13C-nuclear magnetic resonance spectroscopy. Carbohydr Res (1992) 0.82
Development of pulmonary infection in mice inoculated with Blastomyces dermatitidis conidia. Am J Respir Crit Care Med (1994) 0.82
Human immune response to a peptide mimic of Neisseria meningitidis serogroup C in hu-PBMC-SCID mice. Hybridoma (1999) 0.80
An infant rat model of bacteremia with Brazilian purpuric fever isolates of Haemophilus influenzae biogroup aegyptius (Haemophilus aegyptius). The Brazilian Purpuric Fever Study Group. Pediatr Infect Dis J (1989) 0.79
Potential virulence factors of Haemophilus influenzae biogroup aegyptius in Brazilian purpuric fever. The Brazilian Purpuric Fever Study Group. Pediatr Infect Dis J (1989) 0.78
A rapid enzymatic procedure for "fingerprinting" bacteria by using pattern recognition of two-dimensional fluorescence data. Clin Chem (1986) 0.77